HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,028,000 | +0.2% | 123,600 | 0.0% | 0.03% | -2.9% |
| Q1 2022 | $6,013,000 | +14.1% | 123,600 | 0.0% | 0.04% | +34.6% |
| Q4 2021 | $5,270,000 | +11.2% | 123,600 | 0.0% | 0.03% | +23.8% |
| Q3 2021 | $4,738,000 | +35.8% | 123,600 | 0.0% | 0.02% | +40.0% |
| Q2 2021 | $3,489,000 | -14.6% | 123,600 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $4,084,000 | -37.2% | 123,600 | -31.3% | 0.02% | -28.0% |
| Q4 2020 | $6,507,000 | -52.0% | 180,000 | -55.0% | 0.02% | -53.7% |
| Q3 2020 | $13,560,000 | – | 400,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |